ATTO Award Disclosure
Chan Steven · SEC Form 4 · Filed Oct 8, 2026
Award
Calculated transaction value
$0
Chan Steven Chief Financial Officer
ATTO
Transaction date
Aug 4, 2026
Public filing date
Oct 8, 2026
Filing lag
Filed 65 days later
ATTO daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 140,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4/A
- Filing identifier
- 0001654907-26-000009
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Attovia Therapeutics, Inc. ATTO Current | Award | Aug 4, 2026 | $0 |